LncRNAs have been widely reported to sponge with miRNAs and thus promote cisplatin resistance in various cancers, for example, lncRNA FGD5-AS1 enhances cisplatin resistance in lung adenocarcinoma by suppressing miR-142 expression [18]. The gene discussed is FGD5; the disease is lung adenocarcinoma.